PG
The Procter & Gamble Company
Quarterly revenue, EPS, free cash flow, valuation, and Rule of 40 scores for The Procter & Gamble Company.
$143.12-1.32 (-0.91%)● Live
Current Narrative
Procter & Gamble is seen as a defensive "sleep well" stock with strong fundamentals (104% ROCE, 75.7% ROE, 59% margins). Mixed Q3 with flat sales but PAT growth (+12%). Down 28% amid sell-offs but institutional money seeking refuge. Market views as undervalued defensive play.
News
Latest Coverage
NewsJan 31
PGHH Q3 FY26 Earnings
Sales ₹1,262 Cr (+1%), PAT ₹301 Cr (+12%), 32% OPM; silent overachiever in FMCG with 104% ROCE, 75.7% ROE.
Stockwatch
NewsJan 30
PG Q2 Earnings
Net sales $22.2B vs est. $22.23B, core EPS $1.88 vs est. $1.87; organic growth 0%; FY2026 guidance in-line to +4% sales, EPS $6.83-$7.09.
@InvestAlphaPro on X
NewsJan 29
Everyone Selling These Stocks
PG down -28%; ran valuations—most not cheap, couple mispriced.
@DividendTalks on X
NewsJan 28
Procter & Gamble Opened Position
Signal of institutional money seeking refuge; defensive with top fundamentals like 59% margins.
@RabudoInvestor on X
NewsJan 18
Lessons from Murray Stahl
Parallels P&G in indexation risks.
Lemon Cakes Investing
Rule of 402025 Q4
18.7
✗ Below 40
Revenue Growth YoY+1.5%
+
FCF Margin+17.2%
History
2024 R40 +19
2025 R40 +19
Company timeline
Earnings release dates
| Quarter | End date | Publication date | Source |
|---|---|---|---|
| 2025 Q4 | 2025-12-31 | 2026-01-22 | Link |
| 2025 Q3 | 2025-09-30 | 2025-10-24 | Link |
| 2025 Q2 | 2025-06-30 | 2025-07-29 | Link |
| 2025 Q1 | 2025-03-31 | 2025-04-24 | Link |
| 2024 Q4 | 2024-12-31 | 2025-01-22 | Link |
| 2024 Q3 | 2024-09-30 | 2024-10-18 | Link |
| 2024 Q2 | 2024-06-30 | 2024-07-30 | Link |
| 2024 Q1 | 2024-03-31 | 2024-04-19 | Link |
| 2023 Q4 | 2023-12-31 | 2024-01-23 | Link |
| 2023 Q3 | 2023-09-30 | 2023-10-18 | Link |
| 2023 Q2 | 2023-06-30 | 2023-07-28 | Link |
| 2023 Q1 | 2023-03-31 | 2023-04-21 | Link |
| 2022 Q4 | 2022-12-31 | 2023-01-19 | Link |
| 2022 Q3 | 2022-09-30 | 2022-10-19 | Link |
| 2022 Q2 | 2022-06-30 | 2022-07-29 | Link |
| 2022 Q1 | 2022-03-31 | 2022-04-20 | Link |
| 2021 Q4 | 2021-12-31 | 2022-01-19 | Link |
| 2021 Q3 | 2021-09-30 | 2021-10-19 | Link |
| 2021 Q2 | 2021-06-30 | 2021-07-30 | Link |
| 2021 Q1 | 2021-03-31 | 2021-04-20 | Link |
| 2020 Q4 | 2020-12-31 | 2021-01-20 | Link |
| 2020 Q3 | 2020-09-30 | 2020-10-20 | Link |
| 2020 Q2 | 2020-06-30 | 2020-07-30 | Link |
| 2020 Q1 | 2020-03-31 | 2020-04-17 | Link |
Background
Company History
ExchangeNYSE
IPO DateJan 1, 1890
Shares Outstanding2.42Bi
1837
Founding of Procter & Gamble
William Procter and James Gamble partnered in Cincinnati after marrying sisters, focusing on candles and soap.
1887
Introduction of Profit-Sharing Program
William Arnett Procter implemented profit-sharing for employees to reduce strikes and boost engagement.
1911
Launch of Crisco
Introduced vegetable oil-based shortening, diversifying from animal fats into food products.
1946
Introduction of Tide Detergent
Launched Tide, a breakthrough detergent that revolutionized cleaning and became a global leader.
1961
Test-Market of Pampers Diapers
Test-marketed disposable Pampers, shifting from cloth diapers.
2005
Acquisition of Gillette
Acquired Gillette for $57 billion, forming the largest consumer goods company, adding brands like Duracell.
2014
Major Restructuring
Dropped ~100 brands to focus on 65 core ones; sold beauty brands to Coty for $13 billion.
2025
Announcement of Layoffs
Planned 7,000 layoffs over two years due to tariff uncertainties in second Trump administration.
Leadership
Key Players
Shailesh Jejurikar
President and Chief Executive OfficerCEO since January 2026, succeeding Jon Moeller. Joined P&G in 1989 and held senior leadership roles across Fabric Care, Home Care, and multiple global regions. Previously served as Chief Operating Officer. Led development of supply chain, IT, and global business services strategies.
Jon Moeller
Executive Chairman of the BoardExecutive Chairman since January 2026, previously President and CEO (2021–2025). Architect of P&G's integrated portfolio, superiority, productivity, and organization strategy that drove one of the most significant transformations in the company's history. Former CFO (2009–2021).
Andre Schulten
Chief Financial OfficerCFO overseeing P&G's financial planning, investor relations, treasury, and capital allocation. Manages financial strategy for a ~$85B revenue consumer staples giant across 70+ countries.
Jennifer Davis
Chief Executive Officer, Health CareLeads P&G's Health Care segment including Oral-B, Crest, Vicks, and other personal health care brands. Over 8 years in senior leadership at P&G.
Sundar Raman
Chief Executive Officer, Fabric & Home CareLeads P&G's largest segment covering Tide, Ariel, Downy, Dawn, Febreze, Gain, and Swiffer. Over 7 years in senior P&G leadership.
Susan Whaley
Chief Legal Officer and SecretaryLeads P&G's global legal, corporate governance, and compliance functions. Oversees regulatory affairs and intellectual property across all markets.
Short Interest
Short interest data unavailable for PG.
